RxSight (RXST) Change in Acquisitions & Divestments (2020 - 2026)

RxSight (RXST) has reported Change in Acquisitions & Divestments for 7 consecutive years, with $100.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Acquisitions & Divestments rose 100.0% year-over-year to $100.0 million; the trailing twelve-month figure through Jun 2026 stood at $360.0 million (up 53.85% YoY), and the FY2025 full-year result was $260.0 million, up 7.0% from the prior year.
• Change in Acquisitions & Divestments eased to $100.0 million in Q2 2026 per RXST's latest filing, from $110.0 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $110.0 million in Q1 2026 and bottomed at $45.0 million in Q2 2022.
• Historically, Change in Acquisitions & Divestments has averaged $67.9 million across 5 years, with a median of $60.0 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments jumped 400.0% in 2022, then slumped 33.33% in 2023.
• Over 5 years, Change in Acquisitions & Divestments stood at $45.0 million in 2022, then advanced by 11.11% to $50.0 million in 2023, then increased by 10.0% to $55.0 million in 2024, then soared by 63.64% to $90.0 million in 2025, then advanced by 11.11% to $100.0 million in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $100.0 million, $110.0 million, and $90.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.